ellipticine has been researched along with Adenocarcinoma in 2 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, C | 1 |
| Zhang, XM | 1 |
| Tavaluc, RT | 1 |
| Hart, LS | 1 |
| Dicker, DT | 1 |
| Wang, W | 1 |
| El-Deiry, WS | 1 |
| Auclair, C | 1 |
| Pierre, A | 1 |
| Voisin, E | 1 |
| Pepin, O | 1 |
| Cros, S | 1 |
| Colas, C | 1 |
| Saucier, JM | 1 |
| Verschuere, B | 1 |
| Gros, P | 1 |
| Paoletti, C | 1 |
2 other studies available for ellipticine and Adenocarcinoma
| Article | Year |
|---|---|
The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Colonic Neoplasms; DNA-Binding Proteins; Drug Synergism; Elli | 2009 |
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry, | 1987 |